Recent Finacing
Recent Raise
Brii Bio develops therapies for infectious, liver, and CNS diseases—advancing HBV, COVID-19 antibodies, antibiotics and HIV candidates—operating in China and the U.S. with Vir, AliHealth and WuXi partnerships.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Brii Biosciences.
